about
Radioisotopes for metastatic bone painCalcitonin for metastatic bone painBisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysisAddition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.The Regulation of Matrix Metalloproteinase Expression and the Role of Discoidin Domain Receptor 1/2 Signalling in Zoledronate-treated PC3 Cells.WITHDRAWN: Radioisotopes for metastatic bone pain.The application of genomic and molecular data in the treatment of chronic cancer pain.Zoledronate for metastatic bone disease and pain: a meta-analysis of randomized clinical trials.Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis.Risk stratification in the hormonal treatment of patients with prostate cancerIbandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trialsBisphosphonates in the Treatment of Patients With Metastatic Breast, Lung, and Prostate Cancer: A Meta-Analysis.The Italian cross-sectional survey of the management of bone metastasis: ZeTa study.The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment optionsPathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases.Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature.The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.Risk of skeletal-related events in patients with advanced prostate cancer treated with pamidronate or zoledronic acid.The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.Bisphosphonates for advanced prostate cancer.Pain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trials.Angiogenesis in the Development of Medication-Related Osteonecrosis of the Jaws: An Overview.
P2860
Q24235589-D4EAFF43-4882-490A-BED8-6EF8FD7C9FB6Q24245128-68579A68-0419-4AD4-B7E9-334B13FA164EQ24608900-A9A8398D-EE85-46BC-9C96-878FA9AA72AAQ26771537-2A4B726B-F8D5-4003-942E-53A060907C06Q30664167-45BE6859-37B5-4D70-A7AA-FAA862781A37Q33440341-6F3DDEE2-6D51-4C28-99AD-24CE41EDB344Q34207230-D82AF5FB-30AA-45A6-8882-631AB2088A05Q34320376-B6870E4C-96EA-467D-8752-DFD0C1F58F52Q34617885-CF788050-2EA5-4139-8F93-69C2CA68ADE3Q35076189-DAB2CA51-965A-4DE0-B189-4709C19C496DQ35650666-AA7EEBD9-7D6A-4394-B049-766E4F3F93FDQ36299278-378036C5-7DE6-45DA-8FB1-2E4FE18921F1Q36491369-28B57E39-434C-4B56-8C71-1B0D731C80F3Q36673477-D84B86F0-60F2-41D2-A404-2A6E153F83D5Q36798749-B78B2E86-09D4-4857-AE02-FF6F134D25F0Q37187646-5A7D69E9-8BEB-4B41-98CB-8E16FB24F0B5Q37403207-9271A951-0F75-4A41-8B9A-28C436A7AE5BQ37907386-8A27BA2B-0D97-41F0-A6E4-03A0C1591EAAQ41450381-2AEE4B73-5883-4528-9F22-F08FBAC16B22Q42947657-2347512D-E079-43F9-948F-DD8CB43F8A9AQ44884003-B9432BD3-E8CB-4665-9653-35C48CB89057Q47248454-8A7EA5A4-8050-40C0-9CA0-037F65FA3CC9Q48260186-B792A4F3-D0D2-4357-BBE4-74EA38F1D053Q55265048-03F1958F-E80F-47F1-BBF8-DDA73549C5A2
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Bisphosphonates for advanced prostate cancer
@ast
Bisphosphonates for advanced prostate cancer
@en
Bisphosphonates for advanced prostate cancer
@en-gb
Bisphosphonates for advanced prostate cancer
@nl
type
label
Bisphosphonates for advanced prostate cancer
@ast
Bisphosphonates for advanced prostate cancer
@en
Bisphosphonates for advanced prostate cancer
@en-gb
Bisphosphonates for advanced prostate cancer
@nl
prefLabel
Bisphosphonates for advanced prostate cancer
@ast
Bisphosphonates for advanced prostate cancer
@en
Bisphosphonates for advanced prostate cancer
@en-gb
Bisphosphonates for advanced prostate cancer
@nl
P2093
P2860
P1476
Bisphosphonates for advanced prostate cancer
@en
P2093
Kwok Keung Yuen
Malcolm Mason
Mike Shelley
Timothy J. Wilt
Wai Man Sze
P2860
P356
10.1002/14651858.CD006250
P577
2006-10-18T00:00:00Z